Real-time enrollment status for this lymphoma, t-cell clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 2:52 AM UTC
| NCT Number | NCT03161223 |
| Recruiting Status | Recruiting |
| Condition | Lymphoma, T-Cell |
| Phase | PHASE1 |
| Target Enrollment | 148 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Virginia |
| Last Updated on CT.gov | March 31, 2022 (Mar 31, 2022) |
As of July 20, 2026: Clinical trial NCT03161223 is currently recruiting participants. This phase1 study for lymphoma, t-cell is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Virginia. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03161223 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03161223 was last updated Mar 31, 2022 (March 31, 2022). HelloStudys verifies this status automatically.